Cys by Arg in peptide 24 (mimicking a mutation in chronic granulomatous disease) abolished binding; 7) the same replacement in peptide 28 did not affect binding, indicating the existence of an additional binding site. Our results reveal an essential role for the Cys-Gly-Cys triad in Nox2 in binding p67 phox , seconded by an additional binding region, comprising residues C terminal to Cys-Gly-Cys. The 2 regions interact with distinct partner sites in p67 phox .
into the cytosol, known as the dehydrogenase region. The aim of this study was to identify and characterize region(s) in Nox2 acting as binding site(s) for p67 phox . For this purpose, we measured the binding of recombinant p67 phox to an array of 91 overlapping synthetic pentadecapeptides covering the length of the dehydrogenase region (residues 288-570). We found that: 1) p67 phox binds to a site corresponding to residues 357-383, represented by a cluster of 5 peptides (Nos. 24-28); 2) maximal binding was to peptides 24 (357-371) and 28 (369-383); 3) these shared a 369 Cys-Gly-Cys 371 triad, found to be responsible for binding; 4) the Cys-Gly-Cys triad was present in Nox2 of mammals, birds, and amphibians but was absent in other Nox; 5) substituting a Nox4 or Nox1 sequence for the Nox2 sequence in peptide 24 abolished binding; 6) replacing 369 Cys by Arg in peptide 24 (mimicking a mutation in chronic granulomatous disease) abolished binding; 7) the same replacement in peptide 28 did not affect binding, indicating the existence of an additional binding site. Our results reveal an essential role for the Cys-Gly-Cys triad in Nox2 in binding p67 phox
Introduction
Among the mediators of the killing of pathogenic microorganisms by phagocytes, ROS occupy a central position. All ROS produced by phagocytes originate from O 2 .2 , which is generated by the 1 electron reduction of O 2 by a complex of proteins, known as the NADPH oxidase complex, with NADPH serving as the electron donor (reviewed in refs. [1, 2] catalyzed by Nox2; all of the other components of the complex have exclusively regulatory functions. Nox2 contains 570 residues and comprises 6 transmembrane a-helices linked by 3 outside-facing loops and 2 cytosol-facing loops and a cytosolic segment, which extends from residues 288 to 570, also known as the dehydrogenase region (DHR). As the only catalytic component, Nox2 contains 3 redox stations carrying the electrons from NADPH to O 2 . These are an NADPH-binding site and noncovalently bound FAD, present in the DHR, and 2 nonidentical hemes, linked to the third and fifth transmembrane helices. From an evolutionary perspective, the DHR is homologous to the prokaryotic protein ferredoxin-NADP + reductase, which also possesses NADP-and FAD-binding domains [3] . O 2 .2 production by the NAPDH oxidase is rigorously regulated; it does not occur in the resting phagocyte and is initiated by the interaction of membrane receptors with a variety of stimulatory ligands, typified by phagocytosed microorganisms. Thus, in the resting state, there is no electron flow along the redox centers in Nox2, this being initiated by a conformational change in Nox2, consequent to its interaction with the cytosolic components that translocate to the membrane. The process, known as NADPH oxidase assembly, generates a functional NADPH-consuming, O 2 .2 -generating, membrane-anchored complex (reviewed in ref. [4] ). Under physiologic conditions, p47 phox , p67 phox , and Rac are all required for the induction of O 2 .2 production, but whether direct interaction of all components with the Nox2 DHR is required is a yet-unsettled question. The predominant view is that the key component responsible for the remodeling of Nox2 is p67 phox , in conjunction with Rac-GTP [5] [6] [7] .
Therefore, the identification of the region(s) in Nox2 DHR and p67
phox , participating in the interaction between the two is essential for understanding the molecular basis of Nox assembly. Paradoxically, whereas progress was made in the description of binding sites in Nox2 DHR for p47
phox [8] and Rac [9] , there is a surprising lack of information on region(s) in Nox2 DHR participating in binding of p67 phox . More is known about regions in p67 phox involved in oxidase activation, in general, and in interaction with Nox2, in particular. An activation domain (AD), comprising residues 199-210 [10] , or a wider region, extending from residue 190 to 208 [11] in p67 phox , was found to be essential for oxidase activation but not for the actual p67
phox -Nox2 interaction. Experimental data related to the latter are scarce and merely suggest that the binding site for Nox2 in p67
phox is located N terminal to residue 199 [12, 13] .
In the present work, we intended to identify the region(s) in Nox2 DHR engaged in interaction with p67
phox by the use of a peptide array methodology (reviewed in refs. [14, 15] .). We applied this successfully in the past to detect the binding sites in p47 phox for p67 phox [16] , in p22 phox for p47 phox [17] , and for characterizing the epitope in p22 phox recognized by a mAb [18] . Ninety-one overlapping 15-mer peptides, corresponding to the DHR of Nox2 and spanning residues 288-570, were used (overlap of 12 residues; offset of 3 residues). The peptides were attached to 96-well plates and reacted with recombinant p67
phox with an N-terminal 6His tag (r6His-p67 phox ) in the fluid phase, and peptide-bound p67 phox was detected by an antipolyhistidine antibody. The mapping of Nox2 residues shared by clusters of peptides binding p67 phox led to the identification of several potential p67 phox -binding determinants. Intrinsic to the peptide array methodology is the possible occurrence of nonspecific results. A considerable effort was made to distinguish these from sequence-specific binding. This led to the identification of an area in the Nox2 DHR, extending from residue 357 to 383, which "lighted up" by virtue of the binding of p67 phox to a cluster of 5 peptides (numbered [24] [25] [26] [27] [28] , the first (peptide 24) and the last (peptide 28) exhibiting maximal binding ability. All 5 peptides shared a Cys-Gly-Cys (CGC) triad (residues 369-371) located at the C terminus and N terminus of peptides 24 and 28, respectively. Our results reveal an essential role for the CGC triad in Nox2 in the binding of p67 phox , seconded by an additional CGC-independent interaction region, comprising residues C terminal to the CGC triad.
MATERIALS AND METHODS

Synthetic peptides
Two categories of synthetic peptides were used. The first comprised 91 overlapping, 15-residue peptides (PepSets), spanning the DHR of Nox2 from amino acids 288 to 570, with an overlap of 12 residues and an offset of 3 residues. The peptides had a biotin tag at the N terminus, attached by a SerGly-Ser-Gly spacer, and a C-terminal amide. These peptides were synthesized by the multipin synthesis method [19] by Mimotopes (VIC, Australia) and were not purified and served for screening purposes only. The purity of the peptides ranged from 60 to 70% (based on random sampling by the manufacturer) but was not known at the level of individual peptides. The peptides, numbered from 1 to 91, their individual amino acid sequences, and their position in the Nox2 DHR protein sequence are listed in Fig. 1 . The second category consisted of individual peptides of a purity of $70%, selected on the basis of the preliminary screening with the unpurified peptides. These were also 15-residues long, with a biotin tag at the N terminus (attached by a Ser-Gly-Ser-Gly spacer) and a C-terminal amide. Some peptides were synthesized with a biotin tag at the C terminus (attached by a Gly-Ser-Gly-Lys or an aminoethoxy ethoxy acetic acid-Lys spacer) and an acetyl at the N terminus. The purified peptides were synthesized by Mimotopes or Bachem (Bubendorf, Switzerland). Peptide purity was checked by reversed-phase chromatography and the molecular mass confirmed by MALDI-mass spectroscopy, both performed by the peptide manufacturers. In specific peptides, a Cys residue was replaced by Arg or Ser in the course of the synthesis. The absence of the cysteine residue was confirmed by quantification of the sulfhydryl groups by the method of Ellman [20] . Peptides were dissolved in a mixture of 75 parts 1-methyl-2-pyrrolidone (NMP) and 25 parts water (v/v) to a concentration of 1.5 mM to serve as stock solutions for further dilution. The peptide solutions were subjected to sonication by use of 5, 10 s pulses in a VCX 400 W ultrasonic processor equipped with a cup horn filled with an ice-water mixture (Sonics & Materials, Newtown, CT, USA). The peptide stock solutions were divided into 100 ml aliquots and kept frozen at 275°C. Working solutions were freshly prepared on the day of performing the experiments.
Chemicals and reagents
Common laboratory chemicals, at the highest purity available, were purchased from Sigma-Aldrich (St. Louis, MO, USA) or Merck KGaA (Darmstadt, Germany). Tween 20 (Product. No. P1379), casein sodium salt (Product No. C8654), and imidazole (Product No. I0250) were purchased from SigmaAldrich. Mouse antipolyhistidine mAb, peroxidase conjugate (Clone HIS-1; product no. A7058) was obtained from Sigma-Aldrich.
Anti-p67 phox C-19 (goat polyclonal, raised against a peptide mapping within residues 476-526 of human p67 phox ), anti-p67 phox H-300 (rabbit polyclonal, raised against residues 1-300 of human p67 phox ), and anti-p67 phox N-19 (goat polyclonal, raised against a peptide within residues 2-52 of human p67 phox ) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Second anti-goat IgG and anti-rabbit IgG antibodies, conjugated with peroxidase, were obtained from Jackson ImmunoResearch (West Grove, PA, USA). Tetramethyl benzidine + substrate chromogen reagent (Reference S1599) was obtained from DakoCytomation (Glostrup, Denmark).
Preparation of recombinant proteins
Recombinant p67
phox (rp67phox), full-length (residues 1-526), as well as truncations p67 phox (1-212), , and (1-186) with an N-terminal 6His tag were expressed in Escherichia coli and purified on nickel sepharose, as described before [21] . The protein concentration of the recombinant proteins was measured by the method of Bradford [22] , with bovine g-globulin as a standard. The level of purity of the recombinant proteins was assessed by SDS-PAGE analysis. The purified proteins were stored, dissolved in PBS, supplemented with 30% v/v glycerol, divided into small aliquots, and frozen at 275°C. Recombinant maltose binding periplasmic protein (MBP) from E. coli with a 6His N-terminal tag was constructed by use of the expression vector pET-30a (Novagen; EMD Chemicals, Merck KGaA, Darmstadt, Germany), carrying cDNA and encoding residues 29-392 of MBP, preceded by the sequence MHHHHHHSGKT and followed by residues NSSS, and introduced into E. coli Rosetta 2(DE3)pLysS cells (Novagen). The protein was expressed and purified as done with p67 phox .
Measuring peptide-protein binding by a kinetic ELISA
This assay was used to assess the binding of p67 phox and of unrelated proteins in solution to surface-attached synthetic Nox2 peptides. The procedure is a thoroughly modified version of that described before [16, 17] . The original assay was an end-point procedure, which even under the most optimal conditions, was shown to be "semiquantitative." This is a result of the fact that the relationship between absorbance and the amount of bound enzyme is not linear over time, and thus, absorbance read at end point might be a plateau value, identical for reactions with different slopes. For the present study, we developed a modification of the kinetic ELISA [23, 24] , in which data are expressed by the linear segment of the change in absorbance curve over time.
A detailed description of the modified procedure is presented here. All binding experiments were performed with streptavidin-coated, 96-well plates (BioBind Assembly, streptavidin-coated, Cat. No. 95029263; Thermo Electron, Vantaa, Finland). These plates have a streptavidin-coated area, corresponding to a volume of 200 ml/well, and a binding capacity of 25 pmol biotin/well. All of the solutions used in the binding assay were filtered through 0.45 mm poresize filters (Supor 450 membrane filters; Pall, Ann Arbor, MI, USA). To the wells was added 300 ml/well PBS, supplemented with 0.1% v/v Tween 20 and 1% w/v casein (PBS-T-Cas), and the plates were kept at room temperature for 1 h to prevent nonspecific attachment of peptides and proteins to the well surface. The wells were washed 4 times with 300 ml/well PBS, containing 0.1% v/v Tween 20 (PBS-T), with the use of an automatic microplate washer (Wellwash Ascent; Labsystems Oy, Helsinki, Finland) fitted with a "cell wash head" (Code N10802), found, in preliminary experiments, to be optimal for not disrupting low-affinity protein-protein interactions. Synthetic Nox2 peptides, with a biotin tag at the N or C terminus, were first diluted from the original 1.5 mM concentration in 75% NMP/25% water to a concentration of 100 mM in PBS, followed by further dilution to a concentration of 1 mM in PBS supplemented with 1% casein (PBS-Cas), on the day of the performance of the experiment. Volumes (200 ml/well; corresponding to 200 pmol/well, representing an 8-fold excess over the biotin-binding capacity of the wells) were added, the plates were incubated for 1 h at room temperature, and the well contents were mixed on an orbital shaker. After removing the unattached Figure 1 . List of overlapping synthetic peptides covering the DHR of Nox2 (from residue 288 to 570) used in the binding of p67 phox to Nox2 peptide experiments. The complete list of peptides (numbered from 1 to 91) is shown, with an overlap of 12 residues and an offset of 3 residues. The only exception is peptide 91 (marked with an asterisk), which overlaps peptide 90 by 14 residues. The numbers of individual peptides, appearing as vertical columns, are used to identify the particular peptides throughout the article. The numbers at the N and C termini of each peptide indicate the location of the corresponding 15 residues in the amino acid sequence of Nox2. The 4 additional residues (SGSG), added at the N terminus as a spacer between the biotin and the peptide, are not shown. Peptides highlighted in yellow represent members of a cluster exhibiting a significant ability to bind full-length p67 phox (1-526) (see Fig. 3A ). The numbers in red font at the right of the list of peptides indicate the numbers of the peptides comprising a cluster.
peptide by 4 washes with 300 ml/well PBS-T, the wells were filled with 200 ml vol p67 phox (or control proteins) at a concentration of 1.5 mM in PBS-Cas (corresponding to 300 pmol/well) and the plates kept for 16-18 h at 4°C, with mixing on an orbital shaker. After removal of unattached p67 phox by 4 washes with 300 ml/well PBS-T, 200 ml/well of a 1/3000 dilution of peroxidaseconjugated antipolyhistidine antibody in PBS-T-Cas was added and the plate incubated for 1 h at room temperature, with mixing on an orbital shaker. Unbound antibody was removed by 4 washes with 300 ml/well PBS-T, followed by 2 washes with PBS. Bound, peroxidase-conjugated antibody was quantified by adding 200 ml/well TMB + substrate chromogen reagent and measuring the increase in absorbance at 650 nm over time for 10 min in a SpectraMax 340 microplate reader, fitted with SoftMax Pro 5.2 software (Molecular Devices, Sunnyvale, CA, USA) in the kinetic mode. Forty-one readings were made at 15 s intervals, and the content of the wells was mixed for 30 s before the start of reading and for 3 s between readings to compensate for the consumption of the peroxidase substrate in the fluid phase closest to the well surface. Results were expressed as increase in milliabsorbance units at 650 nm/min (absorbance at 650 nm 3 1000/min),-the calculation based on the linear segment of the curve. A schematic representation of the kinetic ELISA is shown in Fig. 2 . In a limited number of experiments, a 2-step antibody detection system was used. This consisted of incubation with antip67 phox antibody C-19, or another anti-p67 phox antibody (1/1000 dilution in PBS-T-Cas, 200 ml/well) for 1 h, followed by 4 washes with PBS-T and incubation with peroxidase-conjugated anti-IgG (1/5000 dilution in PBS-T-Cas, 200 ml/well) for 1 h. From this point on, the procedure was identical to that described above for peroxidase-conjugated antipolyhistidine antibody.
Graph plotting and statistics
The plotting of graphs and kinetic analyses was executed by use of GraphPad Prism Version 6.05 (GraphPad Software, San Diego, CA, USA) and SigmaPlot Version 2000 (SPSS, Chicago, IL, USA). Statistical analysis of comparing the means and SEM of 2 groups was performed by unpaired t test.
RESULTS
Detection of a binding site for p67 phox in the DHR of Nox2 by a peptide array assay-methodological aspects Peptide arrays were used successfully in the past for the identification of sequences involved in protein-protein interactions essential for the assembly of the NADPH oxidase complex [16, 17] . We now applied this method to identify and characterize the region(s) in the DHR of Nox2 responsible for interacting with p67
phox . Ninety-one overlapping, unpurified Nox2 DHR 15-mer peptides, with a biotin tag at the N terminus, were attached to streptavidin-coated, 96-well plates and allowed to react with r6His-p67 phox (1-526). The methodology differed from that used before by the following: 1) All recombinant proteins had a 6His tag at the N terminus; 2) detection of binding of the proteins to the peptides was based on the use of a single antipolyhistidine mAb peroxidase conjugate, able to react with full-length and truncated forms of p67 phox and with the control proteins, with no need for a second antibody; and 3) the conventional ELISA was replaced by a kinetic assay, with an improved quantification capability. The choice of the antipolyhistidine antibody was the consequence of extensive preliminary experiments, in which we tested several anti-p67 phox antibodies (listed under Materials and Methods), followed by peroxidaseconjugated anti-IgG antibody. With the exception of anti-p67 phox C-19, reacting with a C-terminal epitope, none of the other antibodies was suitable for detection, as a result of a number of reasons, comprising lack of recognition of truncated forms of p67 phox , cross-reaction with sequences in Nox2 DHR, or the involvement of the anti-p67 phox epitope in binding of p67 phox to the Nox2 peptides.
p67
phox binds to several peptide clusters, corresponding to specific regions in Nox2 DHR, some of which are shared with p47 phox As apparent in Fig. 3A , full-length p67 phox (1-526) binds to 5 clusters of peptides, composed of peptides 3-12, 24-28, 46-48, 53-54, and 72-73. A positive cluster was defined by the majority of the peptides in the cluster, binding p67 phox at a level at least twice the mean value of binding of p67 phox to wells not coated phox to peptides 24 and 28, compared with binding to wells in the absence of peptides, was statistically significant (P # 0.020 for unpurified and # 0.016 for purified peptides). The binding of p67 phox to purified peptides 25 and 27 (but not to peptide 26) was also statistically significant (P # 0.016). Results in all 3 panels represent means 6 SEM of 3 experiments.
with the peptides (appearing as a horizontal line along the x-axis). The residues forming the clusters are indicated in Fig. 1 by highlighting in yellow. The specificity of p67 phox binding was explored by measuring the binding to Nox2 peptides of the cytosolic component p47
phox phox (1-390), possessing a pI of 9.12, also binds to the same clusters does not support this.
To clarify this issue, we examined the effect of raising the ionic strength of the buffer, in which the p67 phox -peptide interaction was assessed by increasing the concentration of NaCl from 137 to 500 mM. Considering the variability of absolute binding values (see possible reason for this in Discussion), it was essential to run experiments in which binding under various buffer conditions was compared in parallel, by use of the same batches and dilutions of peptides, p67 phox , antibody, and other reagents, as well as the same experimental conditions. The increase of the ionic strength conserved the binding of p67 phox to cluster 24-28 but eliminated binding to clusters 3-12 and 72-73 and reduced binding to clusters 46-48 and 53-54 ( Fig. 4B compared with Fig.  4A, lower) . We noticed an increase in binding to the individual peptide 28 at high ionic strength, a finding that was confirmed with purified peptide 28 (result not shown) and is referred to in Discussion.
Yet another possible reason for nonspecific binding of p67 phox was an interaction between the polyhistidine tag on the recombinant protein and Nox2 DHR peptides. Thus, we assessed the binding of p67 phox (1-526) to Nox2 DHR peptides in the presence of 200 mM imidazole, a known competitive inhibitor of histidine, by virtue of the presence of an imidazole side chain in histidine [25] . As seen in Fig. 4C , in the presence of 200 mM imidazole, the binding of p67 phox to cluster 24-48 was undisturbed, whereas binding to clusters 3-12, 46-48, and 72-73 was eliminated and that to cluster 53-54 reduced.
As shown in Fig. 3B (1-390) (pI = 9.12), and the inhibitory effect of high salt and imidazole suggests that binding to these clusters might involve a mechanism distinct from electrostatic interaction.
These results support the hypothesis that some residues in the peptides in cluster 24-28 represent a specific interaction site for p67 phox and that binding does not involve electrostatic or polyhistidine tag-dependent mechanisms.
The binding of p67
phox to the DHR of Nox2 is centered on 2 Nox2-specific vicinal cysteines An unexpected finding was the atypical pattern of p67 phox binding to cluster 24-28, characterized by maximal binding to peptides 24 and 28 and bidirectional decrease in binding toward peptide 26 (Fig. 3A, inset) . A look at the peptides arranged in an overlapping fashion revealed that all 5 peptides share a CGC triad, located at the C terminus in peptide 24 and at the N terminus in peptide 28 (Fig. 5A) . In the least-reactive peptide 26, the CGC is located at the center, whereas in peptides 25 and 27, the CGC is located 3 residues from the C and N terminus, respectively. The alignment of the Nox2 sequence, extending from the N terminus of peptide 24 to the C terminus of peptide 28, with the corresponding region of Nox1, -3, -4, and -5, based on Kawahara et al. [27] , demonstrated that the CGC triad was present only in Nox2 (Fig. 5B) . The alignment of the CGC triad in human Nox2 with the corresponding region in other species, based on Kawahara et al. [27] and Davis et al. [28] , showed that the CGC triad is highly conserved in Nox2 of mammals, birds, and amphibians, with a CGG triad, in a position corresponding to the CGC triad, found in fishes (Fig. 5C ). It might also be of interest that a Leu-Gly-Cys triad "reappears" in the same position in the Nox2 equivalent (NoxB) of some filamentous fungi (Podospora anserina, Fusarium graminearum, Magnaporthe grisea; data not shown).
A schematic representation of the location of CGC in peptides 24-28, attached via an N-terminal biotin tag to the streptavidincoated well surfaces, is shown in Fig. 5D . The modeling of peptide 24 with the biotin tag linked to the N terminus via a 4-residues spacer [26] reveals an a-helical core from residues D to A, with an unstructured CGC triad at the C terminus (Fig. 5E) . The most likely interpretation of the maximal binding of p67 phox to peptides 24 and 28, derived from these data, is that binding is to a residue(s) in the CGC triad and that optimal binding correlates with the exposure of CGC to the fluid phase containing p67
phox . In light of these results and of the fact that a vicinal cysteinecontaining sequence ( Effect of C-terminal truncation of p67 phox on binding to Nox2 DHR peptides
To get an idea about the partner structures in p67 phox participating in interaction with Nox2 DHR peptides, we constructed 3 C-terminally truncated forms of p67 phox (Fig. 6C ).
Truncation at residue 212 generates a protein comprising the 4 TPRs, the canonical AD (residues 199-210 [10] ), and the extension of the AD (EAD) (residues 187-193 [29] ). Truncation at residue 198 removes the canonical AD, and truncation at residue 186 removes the canonical AD and the EAD. From this point on, all work was done with purified peptides. As only peptides 24 and 28 and variations of these 2 were used, there was no need to avoid nonspecific binding, and thus, binding experiments were performed in PBS (1-526) to Nox2 peptides in PBS containing 137 mM NaCl (corresponding to a conductivity of 13.6 mS/cm), juxtaposed to the charge values of the peptides. In the same series of experiments, the binding of p67 phox (1-526) to Nox2 peptides in PBS containing 500 mM NaCl (corresponding to a conductivity of 59.0 mS/cm; B) and PBS containing 137 mM NaCl, supplemented with 200 mM imidazole (corresponding to a conductivity of 19.0 mS/cm; C), was assessed. In the presence of 500 mM NaCl, binding of p67 phox to peptides 24 and 28, compared with binding to wells in the absence of peptides, was statistically significant (P # 0.002). In the presence of 200 mM imidazole, binding to peptides 24 and 28, compared with binding to wells in the absence of peptides, was statistically significant (P # 0.002). Results represent means 6 SEM of 3 groups of experiments, each group comprising binding in the 3 conditions described above.
(containing 137 mM NaCl), not supplemented with additional NaCl or imidazole.
As apparent in Fig. 6A , full-length p67 phox (1-526) and all 3 truncated forms were bound with similar affinity to Nox2 peptide 24, but there was a tendency of enhanced binding of p67 phox truncated at residues 198 and 186, as also apparent in other groups of experiments (see Figs. 7A and 9A). It should be noted here that p67 phox (1-526) has a pI of 5.88, whereas the pI of the truncated forms ranges from 8.86 to 9.0, yet another indication for the lack of involvement of an electrostatic mechanism in binding.
The binding to Nox2 peptide 28, however, exhibited a different pattern, with all 3 truncations binding with lesser affinity compared with the full-length protein (Fig. 6B ). This is a first indication that in addition to the shared CGC triad, other residues, which are different in Nox2 peptides 28 and 24, have a role in binding. On the p67 phox aspect of the Nox2-p67 phox interaction, it appears that all residues participating in binding to peptide 24 are present in the N-terminal 1-186 sequence, whereas binding to peptide 28 involves residues (or additional residues) present in the C-terminal 213-526 sequence. These results are to be seen in the context of earlier findings that p67
phox (1-210) was as capable as p67 phox (1-526) of activating the Nox in a cell-free system, but p67 phox (1-198) was inactive [10] . As opposed to this, p67 phox truncated at residues 210 or 199 were both capable of binding to purified cytochrome b 558 , present in the fluid phase, and is gradually distanced from the fluid phase in peptides 25-27. It reappears in an exposed position in peptide 28, although the presence of a 4-residue spacer might affect its accessibility by p67 phox . (E) The modeling of peptide 24 with an N-terminal biotin tag linked to the peptide by a SGSG spacer. The model suggests that the CGC triad, located at the C terminus of the peptide, is likely to be exposed to the fluid phase. The model was prepared by Mobyle RPBS, a web source for structural bioinformatics (Paris Diderot University, Paris, France), as described by Maupetit et al. [26] . [12, 13] , an indication that the p67 phox -Nox2 interaction is required but not sufficient for oxidase activation. [30] . O 2 .2 production was impaired in whole cells and in a cell-free system. The introduction of a C369R mutation in wild-type Nox2 DNA, followed by transfection into 391°CGD PLB-985 cells, led to the generation of cells mimicking the defect in Nox found in phagocytes of patients with 391 + CGD [31] . Translocation of p67 phox and p47 phox from the cytosol to the membrane was reported to be severely impaired in the phorbol ester-stimulated neutrophils of the C369R mutant CGD patient and in a cell-free system derived from the patient's neutrophils [30] . Translocation of both cytosolic components to the phagosomal membranes of PBL-985 cells, transfected with C369R mutant DNA and stimulated with latex particles, was also defective [31] . Nox2 peptides 24 and 28 were synthesized, in which 369 Cys was replaced by Arg (Fig. 7C) . Otherwise, the mutant peptides were identical to the native peptides, containing an N-terminal biotin tag and a SGSG spacer. We confirmed the absence of 1 cysteine by measuring the SH groups in the mutant peptide compared with the native peptide by the method of Ellman [20] . The binding of p67 phox (1-526) and of all 3 truncations to the mutant peptide 24 C369R was markedly reduced (Fig. 7A and D) . The replacement of 369 Cys by Arg in peptide 24 was dictated by the intention to mimic the in vivo mutation causing CGD [30] . However, Arg differs markedly from Cys by both a positive charge, versus the neutral character of Cys, and by a different GRAVY. Thus, a peptide 24 was also synthesized in which 369 Cys was replaced by Ser, an amino acid more similar to Cys by its neutral charge and GRAVY. The binding of p67 phox (1-526) to the mutant peptide 24 C369S was also markedly reduced, demonstrating that the lack of binding to the C369R mutant was not a result of the specific replacement of Cys by Arg (result not shown).
In contrast, the binding of p67 phox to mutant peptide 28 C369R
was similar to that to the unmodified peptide (Fig. 7B) . The binding of the truncated forms of p67 phox was low to unmodified and mutant peptide 28, as expected, based on the results shown in Fig. 6B . The different effect of the C369R "mutation," when introduced in peptide 24, as opposed to peptide 28, was also assessed by measuring binding of p67 phox to the peptides over a wide range of p67 phox concentrations, from 9 to 600 pmol/ well. As apparent in Fig. 8A and B, the binding of p67 phox to the unmodified peptides 24 and 28 exhibited a linear relation to the concentration of p67
phox . The binding of p67 phox to mutant peptide 24 C369R was markedly decreased over the whole concentration range of p67 phox , whereas the binding to mutant peptide 28 C369R overlapped the binding curve to the unmodified peptide. These results indicate that the CGC triad represents the main site responsible for the binding of full-length and truncated forms of p67 phox to peptide 24 but that in peptide 28, residues other than the CGC triad also participate in the binding of fulllength p67
phox . This interpretation of the data is also supported by peptide-scrambling experiments. Thus, peptide 24, in which the location of cysteines in the CGC triad was scrambled by replacing CGC by CCG, did not bind p67 phox (1-526) (result not shown). Furthermore, peptide 28, in which the native sequence CGCDKQEFQDAWKLP was scrambled to CCKEQAKPGDQFDWL, did not bind p67 phox (1-526) (result not shown).
p67
phox does not bind to Nox2 DHR peptides 24, in which the Nox2 sequence was replaced by Nox4 or Nox1, and to peptide 28, in which the Nox2 sequence was replaced by Nox4
The rationale behind the idea of measuring binding of p67 phox to the Nox4 and Nox1 analogs of Nox2 peptides included: 1) that Nox4 is constitutively active, not requiring interaction with cytosolic activators, including p67 phox [32] ; 2) the absence of the CGC triad in Nox4 and Nox1 (Fig. 5B); 3) that Nox1 activity, although not fully dependent on cytosolic activators, is enhanced by interaction with the p47 phox and p67 phox analogs NOXO1 and NOXA1 and in certain situations, with p47 phox and p67 phox [32] . Two peptides were synthesized, comprising sequences derived from Nox4 and Nox1, corresponding by alignment to Nox2 peptide 24 and 1 peptide, consisting of the Nox4 sequence, corresponding to Nox2 peptide 28. The alignments were based on Kawahara et al. [27] . The Nox4 and Nox1 peptides and their alignment with Nox2 peptides 24 and 28 are illustrated in Fig. 9C . Nox4 peptide 24 possesses 47% identity, and Nox1 peptide 24 possesses 33% identity with Nox2 peptide 24; Nox4 peptide 28 possesses 27% identity with Nox2 peptide 28.
As apparent in Fig. 9A , Nox4 and Nox1 peptides 24 were incapable of binding the full-length p67 phox or any of the truncated forms. A similar lack of binding of full-length p67 phox to Nox4 peptide 28 was found; all truncated forms bound to Nox4 peptide 28 at a level inferior, even to the low binding to Nox2 peptide 28 (Fig. 9B) .
The binding of p67
phox to surface-attached Nox2 DHR peptides is governed by the exposure of the CGC triad to the fluid phase
The results described so far were all obtained with Nox2 peptides (unpurified and purified), attached via an N-terminal biotin tag to streptavidin-coated, 96-well plates. By examining peptide cluster 24-28, it became apparent that the location of the biotin tag affects the degree of exposure of the CGC triad to the fluid phase containing p67 phox (Fig. 5D ). In the particular case of peptide 24, although its precise conformation is unknown, modeling suggests the association of optimal binding of p67 phox with the location of the CGC triad at C terminus, thus at the opposite end of the surface-attached biotin tag (Fig. 5E ).
To test this hypothesis further, peptides 24 and 28 were synthesized with a C-terminal biotin tag attached via linkers of a similar length to the one used for attaching biotin to the N terminus. A schematic view of the effect of inverting the location of the biotin tag on the location of the CGC triad in peptides 24 and 28 appears in Fig. 10C . The binding of full-length p67 phox and of p67 phox truncated at residue 212 to peptide 24 with Cterminal biotin was markedly reduced (Fig. 10A) . The placement of biotin at the C terminus of peptide 28 had the opposite effect; the binding of full-length p67 phox was moderately enhanced, and even the minor level of binding of p67 phox truncated at residue 212 got a certain boost (Fig. 10B) .
The modeling of peptide 28 with C-terminal biotin (Fig. 10D ) shows an image similar to that of peptide 24 with N-terminal biotin (Fig. 5E) , exhibiting a central a-helix, followed by an unstructured segment containing the CGC triad. Results shown in Fig. 7B indicated that binding of p67 phox to peptide 28 with Nterminal biotin was predominantly CGC independent, involving residues C terminal to the CGC triad. The fact that placing biotin at the C terminus leads to some enhancement of binding is probably a result of the better exposure of the CGC triad to p67 phox . This suggests that binding to peptide 28 comprises CGCindependent and CGC-dependent elements, their relative participation dictated by their respective exposure to p67 phox . One of the arguments supporting a CGC-independent mechanism for binding of p67 phox to peptide 28 with N-terminal biotin was the persistence of binding to the mutant peptide 28 C369R (Fig. 7B) . Thus, we repeated the experiments shown in Fig. 7 by comparing binding with peptides 24 and 28 with biotin at the N or C terminus. The binding of p67 phox (1-526) and p67 phox (1-212) to the mutant peptide 24 C369R was impaired, independently of the location of biotin (Figs. 7A and 11A) . In sharp contrast, the binding of p67 phox (1-526) and p67 phox (1-212) to the mutant peptide 28 C369R was dependent on the location of the biotin tag. The similar binding to the native and mutant peptide 28, when the biotin was attached to the N terminus, shown in Figs. 7B and 11B, was replaced by lack of binding to the mutant peptide, when biotin was attached to the C terminus (Fig. 11B) .
DISCUSSION
There is multifaceted evidence for a central role of p67 phox in the activation of the NADPH oxidase, culminating in O 2 .2 genera-
tion. This appears to be the result of a direct interaction of p67 phox with the only catalytic component, Nox2. In this conceptual framework, p47 phox and Rac function principally to facilitate the p67 phox -Nox2 interaction, although this is not limited to a passive carrier role. Thus, in addition to the "mechanical" assistance in targeting p67
phox to the membrane environment of flavocytochrome b 558 , Rac molds p67 phox for optimal interaction with Nox2. The first indication for such a course of events came from cell-free activation studies, demonstrating the redundancy of p47 phox , as opposed to the absolute requirement for p67 phox (assisted by Rac) [33, 34] . This was followed by experiments showing that Rac-mediated targeting of p67 phox to the membrane was sufficient for Nox activation in vitro [5, 6] and by similar evidence derived from work with p67 phox -Rac chimeric constructs [35] [36] [37] [38] . Finally, imaging of flavocytochrome b 558 by atomic force microscopy also revealed a paramount role for p67 phox in Nox activation [39] . Therefore, it is surprising that no information is available on the region(s) in Nox2 interacting with p67 phox , except for the assumption that this is likely to be located in the DHR (residues 288-570) or in the cytosolic loops B and D, bound to be accessible to p67 phox . We approached this question by assessing the binding of full-length and truncated forms of 6His-tagged rp67 phox to an array of overlapping 15-mer synthetic peptides covering the entire length of the Nox2 DHR. The interaction was monitored in a system in which the Nox2 peptides were biotin tagged and immobilized to the surface of streptavidin-coated, 96-well plates, and p67 phox was present in a solution covering the wells. The binding of p67 phox to the Nox2 peptides was quantified by a kinetic ELISA, based on the use of a peroxidase-conjugated, antipolyhistidine mAb.
This led to the discovery of a p67 phox -binding region,
represented by peptides 24-28, corresponding to Nox2 residues 357-383. Maximal binding was to peptides 24 (residues 357-371) and 28 (residues 369-383). These 2 peptides share a 369 CGC 371 triad, located at the C terminus of peptide 24 and at the N terminus of peptide 28. The presence of the CGC triad was clearly the reason for preferential binding, as all of the peptides in the cluster have a negative charge and a similar hydrophobic character.
To the best of our knowledge, this is the first description of a well-defined binding site for p67
phox in the DHR of Nox2.
Subjecting this basic finding to detailed analysis led to the following conclusions. 1) The binding is p67 phox specific, as
shown by the lack of binding of p47 phox and MBP.
2) The binding is unrelated to charge, as both the peptides and p67 phox (1-526) have a negative charge expected to lead to repulsion, and the increase in the ionic strength, expected to counter electrostatic attraction, does not interfere with binding.
3) The CGC triad is present in Nox2 but absent in Nox1, -3, -4, and -5. It is well conserved in Nox2 of mammals, birds, and amphibians. 4) Optimal binding of p67 phox is associated with the exposure of the CGC triad to the fluid phase, containing p67
phox . As a result of the geometry of surface-attached peptides, exposure is best in peptide 24 (CGC at C terminus), when surface attached by Nterminal biotin, and in peptide 28 (CGC at N terminus), when surface attached by C-terminal biotin. 5) A clear distinction between peptides 24 and 28 is also evident when binding of various truncated forms of p67 phox is compared: C-terminally truncated forms of p67 phox , at residues 212, 198, and 186, are bound to peptide 24, whereas only full-length p67 phox is bound to peptide 28. 6) The replacement of 369 Cys by Arg or Ser in peptide 24 prevents binding of p67 phox , whereas the same replacement in peptide 28 has no effect on binding. 7) The reversal of the geometry of peptide 28 with a 369 Cys-to-Arg replacement, by C-terminal attachment to the well, which exposes the CGC triad to the fluid phase, results in lack of p67 phox binding. 8) The sequence specificity of binding is also demonstrated by the lack of binding of p67 phox to peptide 24 with scrambled cysteines and to peptide 28 with random residue scrambling. 9) Peptides 24 and 28, in which the Nox2 sequence was replaced by Nox4, and peptide 24, in which the Nox2 sequence was replaced by Nox1, do not bind p67
phox . These results suggest that binding of p67 phox to peptide 24 is predominantly or fully dependent on the CGC triad. It also appears peptide 28 is predominantly CGC independent and probably involves Nox2 residues 372-383; in the p67 phox partner, it probably requires the participation of residues C terminal to residue 212.
Sequence analysis of Nox2 DHR indicates that the region corresponding to peptides 24 and 28 is an insertion in Nox compared with other dehydrogenases that do not require regulatory proteins for activity, making this region a likely candidate-binding site for Nox modulatory proteins. Threedimensional modeling of the Nox2 DHR [40] suggests that the region centered on 369 Cys is surface exposed and well suited for functioning as a docking site for p67 phox [30, 31] . Molecular modeling also indicates that this region is situated at a critical site in the Nox2 DHR, with peptide 24 partially overlapping the ribityl chain-binding subdomain of the FAD-binding domain [28, 41] and peptide 28 adjacent to or part of the "strap" connecting the FAD-and NADPH-binding domains. The involvement of part Results obtained so far indicate that binding of p67 phox involves the establishment of disulfide bonds between cysteine(s) in peptide 24 and cysteine(s) in p67 phox and that the introduction of an intramolecular disulfide bond between 369 Cys and 371 Cys in the peptide markedly enhances binding (ref. [42] and [unpublished results]). It is likely that the variability in absolute binding values, from experiment to experiment, evident in our results, is a result of unavoidable variations in the level of oxidation of cysteines in the Nox2 peptides and/or p67 phox in the course of their preparation, storage, or use in experiments [43] . An important, unsolved question is the identity of the particular cysteine(s) in p67 phox engaged in binding to Nox2. The finding that 3 truncated forms of p67 phox (at residues 212, 198, and 186), all of which contain 4 cysteines, were bound to peptide 24 with an affinity equal or superior to that of full-length p67 phox suggests that cysteine(s) located N terminal to residue 186 were involved.
Another only partially solved problem is the nature of the CGC-independent interaction between peptide 28 and fulllength p67
phox . Our results indicate that no cysteines are involved, although under specific experimental conditions, such as "forced" exposure of the CGC triad to p67 phox , they do contribute to binding. The finding that binding of p67 phox to peptide 28 is augmented at a high NaCl concentration (Fig. 4B ) also suggests a distinct mechanism of binding, probably involving hydrophobic residues in the C-terminal half of the peptide. Also unknown remains the precise identity of the region(s) in p67 phox participating in the CGC-independent interaction.
The lack of binding of p67 phox to the Nox1 analog of peptide 24 should be considered in the context of the fact that Nox1 is subject to regulation by the p67 phox analog NOXA1 and to a certain degree, by p67 phox . The absence of binding might be explained by the Nox1-NOXA1 interaction being mediated by a CGC-independent mechanism, involving residues in Nox1 distinct from those present in peptide 24, or by differences between p67 phox and NOXA1 (only 28% sequence identity, the lack of an N-terminal SH3 domain in NOXA1, and the constitutive presence of NOXA1 in the plasma membrane, thus in close vicinity to Nox1).
Nox2 peptides 24 and 28 were not found to be inhibitory when tested in an earlier study for an effect on NADPH oxidase activation in vitro [44] . As in that work, unpurified Nox2 peptides were screened at a concentration of 10 mM, we reexamined the ability of purified peptides 24 and 28 to inhibit NADPH oxidase activation in a cell-free system over a concentration range of 1.25-40 mM. We found percent inhibition of NADPH oxidase activity values for peptide 24 of 1.11 6 2.02 at 10 mM peptide and 25.28 6 3.90 at 40 mM peptide (means 6 SEM of 7 experiments). For peptide 28, the values were 2.64 6 2.45 at 10 mM peptide and 22.11 6 3.84 at 40 mM peptide (means 6 SEM of 3 experiments). However, the significance of these results was questionable because of the absence of typical sigmoidal dose-response curves and the fact that the mutant peptide 24 C369R exhibited an inhibitory potency similar to that of the native peptide 24. We do not have a ready explanation for this negative result, but both methodological and conceptual parameters might be relevant. Thus, binding studies were performed in a setup, in which the Nox2 peptides were present in the solid phase and p67 phox in the (1-212) to peptide 24, in which C369 was replaced by R (C369R), is markedly reduced compared with binding to the native peptide, whether the biotin tag is attached to the N or C terminus. The lesser binding of p67 phox to native peptide 24 with a C-terminal biotin tag is also evident (as also seen in Fig.  10A ). (B) The binding of p67 phox (1-526) to peptide 28 with an N-terminal biotin tag is not influenced by replacing C369 by R (as also seen in Fig. 7B) . However, the replacement of C369 by R in peptide 28 with a C-terminal biotin tag markedly reduces binding of p67 phox (1-526); the same is true for binding of p67 phox (1-212), although the extent of binding to native peptide 28 is low (as also seen in Fig. 10B) . The difference in binding to the native and mutant peptides 28 with C-terminal biotin was statistically significant for both p67 phox (1-526) and p67 phox (1-212) (P # 0.021). Results represent means 6 SEM of 3 experiments for binding to each of the 2 pairs of peptides tested.
